Clorazepate Dipotassium Tablet
Product Images NDC 51672-4042

4 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 51672-4042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clorazepate 01)

Chemical Structure (Clorazepate 01)
Chemical structure diagram of Clorazepate Dipotassium, showing its molecular arrangement including a chlorinated benzene ring, diazepine core, and potassium salt form with KOH.*
FDA Label Image

Principal Display Panel (3.75 mg Bottle Label)

Principal Display Panel (3.75 mg Bottle Label)
Label for Clorazepate Dipotassium Tablets USP 3.75 mg in a 100-tablet bottle. The label includes storage instructions, dosage information, and manufacturer details (Taro Pharmaceutical Industries Ltd.). The product is marked as Rx only and includes a barcode and trademark information for Taro Pharmaceuticals.*
FDA Label Image

Principal Display Panel (15 mg Bottle Label)

Principal Display Panel (15 mg Bottle Label)
Clorazepate Dipotassium Tablets USP 7.5 mg oral tablets packaging label displaying 100 tablets. Label includes NDC 51672-4043-1, instructions to dispense medication guide, storage conditions, manufacturer Taro Pharmaceutical Industries Ltd., and distributor Taro Pharmaceuticals U.S.A., Inc. Marked as Rx only.*
FDA Label Image

Principal Display Panel (7.5 mg Bottle Label)

Principal Display Panel (7.5 mg Bottle Label)
Label for Clorazepate Dipotassium Tablets USP, 15 mg, oral tablet dosage form. The bottle contains 100 tablets. Label includes NDC 51672-4044-1 and specifies prescription use (Rx only). Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. Storage instructions and dosage guidance are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.